Conclusions
Hopefully, the unprecedent efforts of clinical researchers in the fight against the SARS Cov-2 will result into the identification of effective treatments. This would largely counterbalance the delaying effects of COVID-on ongoing trials for other diseases. However, these efforts might be negatively affected in the absence of guidelines for a more harmonized clinical research and a united commitment of the scientific community to share personal knowledge and data. Allergists and clinical immunologists should have a leading role in this unprecedent challenge.